EXTOD - Active: Study looking at the effect of regular activity on people with Type 1 diabetes

This 6-week study aims to assess how taking regular active breaks can have a positive effect on glucose management and daily insulin dose on sedate people with Type 1 diabetes.

This study is being conducted fully remotely. You will be asked to complete 2 health assessments and wear an activity monitor for five weeks. As part of the study, you may be asked to include “active breaks” into your normal routine. Adding in active breaks will mean completing short three-minute walks on a regular basis. You will get access to a mobile fitness app that will support you in doing this.

Click here to take part
Teilnehmen

Study For

Zielgruppe der Studie

People aged 18-66, who have Type 1 diabetes and spend most of their day sitting or lying down.

Sponsored By

Gesponsert von

Liverpool John Moore University

Participants

Teilnehmenden

100

People

Personen

Participate by

Abschlussdatum

December 31, 2023

31.12.2023

What is expected of me? 

Was wird von mir erwartet?

  • After completing the pre-screener, you will be asked to schedule a telephone or video call with a member of the research team.
  • During this short call, the study team will check your eligibility for the trial and get your consent to participate.
  • If you decide to enrol in the study, you will be randomly assigned to one of two groups: the control group who will continue with their normal lifestyle or the “active breaks” group
  • All study participants will be asked to complete a health assessment at the start. This will include a range of tests (eg blood samples, body measurements etc) as well as questionnaires about lifestyle and medical history. You will be provided all of the equipment to do these tests.
  • All study participants will be asked to wear an activity monitor for 5 weeks.
  • If randomly allocated to the “active breaks” group you will complete a four-week programme of ‘active breaks’ consisting of regular short walks to break up sitting time. During this time you will have access to a mobile fitness app that will prompt you to go for the short walks.
  • At the end of the study, you will be asked to complete a second health assessment.

What is the benefit for me?

Was ist der Nutzen für mich?

The opportunity to explore how activity affects glucose management and daily insulin dose.

Who is the study for? 

Für wen ist die Studie gedacht?

People who:

  • Are aged 18-66 years
  • Have been diagnosed with Type 1 Diabetes for at least 3 years
  • Spend most of the day sitting or lying down (+10 hours)
  • Are not currently completing planned structured exercise (e.g., running, cycling, gym or sports)
  • Using a basal-bolus insulin regimen or insulin pump therapy  
  • Use an Abbot FreeStyle Libre 2 flash glucose monitor
  • Are not on a closed-loop insulin system
  • Are not pregnant or planning to become pregnant
  • Do not have a history of hyperglycaemia (HbA1c >85 mmol/mol)

Complete this questionnaire to take part.

Fülle diesen Fragebogen aus, um herauszufinden, ob Du berechtigt bist